J&J | Ativos



Assets Alterar Data
AbbVie USD 135.16B 8.26B 2024-12
Abbott USD 81.45B 34M 2025-03
Amgen USD 89.37B 2.47B 2025-03
AstraZeneca USD 106.25B 2.22B 2025-03
Baxter International USD 25.78B 894M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Becton, Dickinson and Co. USD 54.47B 198M 2025-03
Biogen USD 28.03B 16.2M 2025-03
Boston Scientific USD 39.4B 1.32B 2024-12
Bristol-Myers Squibb USD 92.43B 176M 2025-03
CONMED USD 2.3B 8.56M 2025-03
Cooper Companies USD 12.22B 93M 2025-01
Dexcom USD 6.75B 267.2M 2025-03
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Eli Lilly USD 89.39B 10.67B 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Globus Medical USD 5.25B 165.71M 2024-12
Hologic USD 8.55B 183.6M 2025-03
Indivior 1.38B 56M 2025-03
Insulet USD 3.09B 62.3M 2024-12
Integra LifeSciences USD 4.04B 28.38M 2024-12
Intuitive Surgical USD 19.22B 477.2M 2025-03
J&J USD 193.67B 13.57B 2025-03
Medtronic USD 89.97B 69M 2025-01
Merck USD 117.11B 426M 2024-12
Merit Medical Systems USD 2.47B 49.37M 2025-03
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 131.89B 906M 2025-03
Stryker USD 46.01B 3.04B 2025-03
Tandem Diabetes Care USD 922.14M 45.52M 2025-03
Teva Pharmaceutical Industries USD 39.33B 2.43B 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12
Zimmer Biomet Holdings USD 21.37B 355M 2024-12
Zoetis USD 14.24B 120M 2024-12



J&J Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.